Finance

Beta
Lists
ILX:TLV
Ilex Medical Ltd
ILA 5,097.00
+0.51%
(+26.00) 1D
Jun 3, 5:24:02 PM GMT+3  ·   ILA
All symbols
SymbolPriceChange% Change
Generating top insights for ILX...
Mkt. cap
570.26M
Avg. vol.
9.26K
Volume
0.00
Dividend
3.90%
Quarterly dividend
ILA 49.66
Ex-dividend date
Apr 10, 2026
P/E ratio
11.12
52-wk high
ILA 7,085.00
52-wk low
ILA 4,501.00
EPS
ILA 4.59
Shares outstanding
11.19M
No. of employees
181
Mkt. cap
570.26M
Avg. vol.
9.26K
Volume
0.00
Dividend
3.90%
Quarterly dividend
ILA 49.66
Ex-dividend date
Apr 10, 2026
P/E ratio
11.12
52-wk high
ILA 7,085.00
52-wk low
ILA 4,501.00
EPS
ILA 4.59
Shares outstanding
11.19M
No. of employees
181
News stories
From sources across the web
About Ilex Medical Ltd
CEOTamar Galili
Employees181
Founded1977
Headquarters-
SectorHealth care provider
Websiteilexmedical.com
Previous reportsAll values in ILS
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in ILS
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
219.31M
227.57M
245.69M
213.57M
Cost of goods sold
169.67M
175.57M
190.34M
164.95M
Cost of revenue
169.67M
175.57M
190.34M
164.95M
Research and development expenses
2.00M
1.97M
1.82M
1.83M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
35.61M
36.26M
38.90M
37.54M
Operating expense
37.44M
37.22M
41.64M
40.64M
Total operating expenses
207.11M
212.80M
231.98M
205.59M
Operating income
12.20M
14.77M
13.70M
7.99M
Other non operating income
7.83M
173.00K
1.05M
3.04M
EBT including unusual items
22.57M
15.90M
23.28M
7.48M
EBT excluding unusual items
23.08M
15.90M
15.72M
7.48M
Income tax expense
5.65M
4.91M
4.75M
2.56M
Effective tax rate
25.02%
30.90%
20.40%
34.23%
Other operating expenses
-168.00K
-1.01M
926.00K
1.26M
Net income
16.92M
10.99M
18.53M
4.92M
Net profit margin
7.72%
4.83%
7.54%
2.30%
Earnings per share
-
-
-
-
Interest and investment income
1.72M
2.10M
1.67M
-
Interest expense
-460.00K
-608.00K
-514.00K
-906.00K
Net interest expenses
1.26M
1.50M
1.16M
-906.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
24.34M
27.62M
22.04M
20.11M
Gain or loss from assets sale
-5.00K
-3.00K
-123.00K
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer